| Date Filed | Type | Description |
| 02/24/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2015 |
4
| Firuta Paul E (President, US Comm Operations) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 1,114 shares
@ $46, valued at
$51.2k
Disposed/sold 58,421 options to buy
@ $23.38, valued at
$1.4M
Disposed/sold 10,905 restricted stock units
@ $0
Disposed/sold 21,386 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| Cvijic Christine Mikail (SVP, Legal Affairs & GC) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 276,955 shares
@ $46, valued at
$12.7M
Disposed/sold 106,643 options
@ $38.27, valued at
$4.1M
Disposed/sold 196,018 options
@ $8.23, valued at
$1.6M
Disposed/sold 104,438 options
@ $8.21, valued at
$857.4k
Disposed/sold 133,125 options
@ $8.25, valued at
$1.1M
Disposed/sold 154,284 options
@ $3.34, valued at
$515.3k
Disposed/sold 67,636 options
@ $3.25, valued at
$219.8k
Disposed/sold 82,826 options
@ $5.71, valued at
$472.9k
Disposed/sold 109,602 options
@ $5.71, valued at
$625.8k
Disposed/sold 80,912 restricted stock units
@ $0
Disposed/sold 19,598 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 13,900 shares
@ $46, valued at
$639.4k
Disposed/sold 36,000 options to buy
@ $4.24, valued at
$152.6k
Disposed/sold 3,816 restricted stock units
@ $0
Disposed/sold 167,608 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| TOMBROS PETER G (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 57,625 shares
@ $46, valued at
$2.7M
Disposed/sold 36,000 options to buy
@ $4.24, valued at
$152.6k
Disposed/sold 3,816 restricted stock units
@ $0
Disposed/sold 171,067 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| Graf Susan E (VP,Corp Development & Strategy) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 9,000 shares
@ $46, valued at
$414k
Disposed/sold 56,500 options to buy
@ $6.95, valued at
$392.7k
Disposed/sold 3,816 restricted stock units
@ $0
Disposed/sold 5,624 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| Selisker Rachel R (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| GRONINGER JAMES G (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| Pauwels Eric (President, NPS Pharma Int'l) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| Friedman Robin D (SVP of Human Resources) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 522 shares
@ $46, valued at
$24k
Disposed/sold 37,390 options to buy
@ $23.38, valued at
$874.2k
Disposed/sold 3,272 restricted stock units
@ $0
Disposed/sold 13,687 restricted stock units
@ $0 |
|
| 02/24/2015 |
4
| Legault Pierre (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/24/2015 |
4
| GRANADILLO PEDRO P (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/23/2015 |
8-K
| Form 8-K - Current report |
| 02/23/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/23/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/20/2015 |
10-K/A
| Annual Report for the period ended December 31, 2014 [amend] |
| 02/20/2015 |
4
| Broom Colin MD (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 3,816 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| Graf Susan E (VP,Corp Development & Strategy) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| Selisker Rachel R (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| TOMBROS PETER G (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 3,816 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| GRONINGER JAMES G (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 3,816 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| Nader Francois (President, CEO and Director) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 20,301 shares
@ $0
Paid exercise price by delivering 7,263 shares
@ $45.85, valued at
$333k
Paid exercise price by delivering 4,943 shares
@ $45.85, valued at
$226.6k
Paid exercise price by delivering 12,600 shares
@ $45.88, valued at
$578.1k
Exercised 5,625 options to buy
@ $3.25, valued at
$18.3k
Exercised 24,466 options to buy
@ $3.34, valued at
$81.7k
Exercised 3,262 options to buy
@ $8.21, valued at
$26.8k
Exercised 653 options to buy
@ $38.27, valued at
$25k
Granted 80,912 restricted stock units
@ $0
Exercised 9,798 restricted stock units
@ $0
Exercised 24,301 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| Rogus Joseph J (SVP, GTO & Supply Chain Mngmt) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| Cvijic Christine Mikail (SVP, Legal Affairs & GC) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| Pauwels Eric (President, NPS Pharma Int'l) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 02/20/2015 |
4
| Firuta Paul E (President, US Comm Operations) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 10,905 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC |
|